Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo

Nanotechnology

Volumn 26, Issue 14, 2015, Pages

  Liu, Yun ^a,b   Ding, Xingwei ^a   Li, Jinghua ^a   Luo, Zhong ^a   Hu, Yan ^a   Liu, Junjie ^a   Dai, Liangliang ^a   Zhou, Jun ^a   Hou, Changjun ^a   Cai, Kaiyong ^a  

^a CHONGQING UNIVERSITY   (China)

^b ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

drug delivery system; in vivo; matrix metalloprotease; mesoporous silica nanoparticles; tumor microenvironment

Indexed keywords

BIOCOMPATIBILITY; BODY FLUIDS; DRUG DELIVERY; MESOPOROUS MATERIALS; NANOPARTICLES; PEPTIDES; REACTION INTERMEDIATES; SILICA; TUMORS;

DRUG DELIVERY SYSTEM; IN-VIVO; MATRIX METALLOPROTEASE; MESOPOROUS SILICA NANOPARTICLES; TUMOR MICROENVIRONMENT;

DRUG THERAPY;

ANTINEOPLASTIC AGENT; DOXORUBICIN; DRUG CARRIER; MATRIX METALLOPROTEINASE; NANOPARTICLE; SILICON DIOXIDE;

ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; ENZYMOLOGY; HEPG2 CELL LINE; HUMAN; METABOLISM; NEOPLASMS, EXPERIMENTAL; NUDE MOUSE; TUMOR MICROENVIRONMENT;

ANIMALS; ANTINEOPLASTIC AGENTS; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HEP G2 CELLS; HUMANS; MATRIX METALLOPROTEINASES; MICE, NUDE; NANOPARTICLES; NEOPLASMS, EXPERIMENTAL; SILICON DIOXIDE; TUMOR MICROENVIRONMENT;

EID: 84925432643     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/26/14/145102     Document Type: Article

References (63)

1. Jemal A, Bray F, Center M M, Ferlay J, Ward E and Forman D 2011 Global cancer statistics CA Cancer J. Clin. 61 69
2. Danhier F, Feron O and Preat V 2010 To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Control. Release 148 135
3. Peer D, Karp J M, Hong S, Farokhzad O C, Margalit R and Langer R 2007 Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnology 2 751
4. Judd J, Ho M L, Tiwari A, Gomez E J, Dempsey C, Van Vliet K, Igoshin O A, Silberg J J, Agbandje-McKenna M and Suh J 2014 Tunable protease-activatable virus nanonodes ACS Nano 8 4740
5. Wang F, Wang Y-C, Dou S, Xiong M-H, Sun T-M and Wang J 2011 Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells ACS Nano 5 3679
6. Bourzac K 2012 Nanotechnology: carrying drugs Nature 491 S58
7. An F F, Cao W and Liang X J 2014 Nanostructural systems developed with positive charge generation to drug delivery Adv. Healthc. Mater. 3 1162
8. Hu Y, Cai K, Luo Z and Jandt K D 2010 Layer-by-layer assembly of β-estradiol loaded mesoporous silica nanoparticles on titanium substrates and its implication for bone homeostasis Adv. Mater. 22 4146
9. Tarn D, Ashley C E, Xue M, Carnes E C, Zink J I and Brinker C J 2013 Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility Acc. Chem. Res. 46 792
10. Ambrogio M W, Thomas C R, Zhao Y-L, Zink J I and Stoddart J F 2011 Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine Acc. Chem. Res. 44 903
11. 2 Adv. Health. Mater. 2 1591
12. Li Z, Barnes J C, Bosoy A, Stoddart J F and Zink J I 2012 Mesoporous silica nanoparticles in biomedical applications Chem. Soc. Rev. 41 2590
13. He Q and Shi J 2011 Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility J. Mater. Chem. 21 5845
14. Luo Z, Cai K, Hu Y, Zhang B and Xu D 2012 Cell-specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity Adv. Healthc. Mater. 1 321
15. Kim H, Kim S, Park C, Lee H, Park H J and Kim C 2010 Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers Adv. Mater. 22 4280
16. Luo Z, Cai K, Hu Y, Li J, Ding X, Zhang B, Xu D, Yang W and Liu P 2012 Redox-responsive molecular nanoreservoirs for controlled intracellular anticancer drug delivery based on magnetic nanoparticles Adv. Mater. 24 431
17. Liu R, Zhang Y, Zhao X, Agarwal A, Mueller L J and Feng P 2010 pH-responsive nanogated ensemble based on gold-capped mesoporous silica through an acid-labile acetal linker J. Am. Chem. Soc. 132 1500
18. Thomas C R, Ferris D P, Lee J-H, Choi E, Cho M H, Kim E S, Stoddart J F, Shin J-S, Cheon J and Zink J I 2010 Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles J. Am. Chem. Soc. 132 10623
19. Giri S, Trewyn B G, Stellmaker M P and Lin V S Y 2005 Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles Angew. Chem. Int. Ed. Engl. 44 5038
20. Patel K, Angelos S, Dichtel W R, Coskun A, Yang Y-W, Zink J I and Stoddart J F 2008 Enzyme-responsive snap-top covered silica nanocontainers J. Am. Chem. Soc. 130 2382
21. Singh N, Karambelkar A, Gu L, Lin K, Miller J S, Chen C S, Sailor M J and Bhatia S N 2011 Bioresponsive mesoporous silica nanoparticles for triggered drug release J. Am. Chem. Soc. 133 19582
22. Zhu C-L, Song X-Y, Zhou W-H, Yang H-H, Wen Y-H and Wang X-R 2009 An efficient cell-targeting and intracellular controlled-release drug delivery system based on MSN-PEM-aptamer conjugates J. Mater. Chem. 19 7765
23. Liu R, Zhao X, Wu T and Feng P 2008 Tunable redox-responsive hybrid nanogated ensembles J. Am. Chem. Soc. 130 14418
24. Luo Z, Cai K, Hu Y, Zhao L, Liu P, Duan L and Yang W 2011 Mesoporous silica nanoparticles end-capped with collagen: redox-responsive nanoreservoirs for targeted drug delivery Angew. Chem. Int. Ed. Engl. 50 640
25. Ma X, Nguyen K T, Borah P, Ang C Y and Zhao Y 2012 Functional silica nanoparticles for redox-triggered drug/ssDNA co-delivery Adv. Healthc. Mater. 1 690
26. Huang Y, He S, Cao W, Cai K and Liang X-J 2012 Biomedical nanomaterials for imaging-guided cancer therapy Nanoscale 4 6135
27. Muhammad F, Guo M, Qi W, Sun F, Wang A, Guo Y and Zhu G 2011 pH-triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids J. Am. Chem. Soc. 133 8778
28. Vivero-Escoto J L, Slowing I I, Wu C-W and Lin V S-Y 2009 Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere J. Am. Chem. Soc. 131 3462
29. Lin Q, Huang Q, Li C, Bao C, Liu Z, Li F and Zhu L 2010 Anticancer drug release from a mesoporous silica based nanophotocage regulated by either a one-or two-photon process J. Am. Chem. Soc. 132 10645
30. Aznar E, Mondragón L, Ros-Lis J V, Sancenón F, Marcos M D, Martínez-Máñez R, Soto J, Pérez-Payá E and Amorós P 2011 Finely tuned temperature-controlled cargo release using paraffin-capped mesoporous silica nanoparticles Angew. Chem. Int. Ed. Engl. 123 11368
31. Xu J-H, Gao F-P, Li L-L, Ma H L, Fan Y-S, Liu W, Guo S-S, Zhao X-Z and Wang H 2013 Gelatin-mesoporous silica nanoparticles as matrix metalloproteinases-degradable drug delivery systems in vivo Microporous Mesoporous Mater. 182 165
32. Curran S and Murray G I 1999 Matrix metalloproteinases in tumour invasion and metastasis J. Pathol. 189 300
33. Sternlicht M D and Werb Z 2001 How matrix metalloproteinases regulate cell behavior Annu. Rev. Cell Dev. Biol. 17 463
34. Yamada T et al 2010 Overexpression of MMP-13 gene in colorectal cancer with liver metastasis Anticancer Res. 30 2693
35. Altadill A, Rodríguez M, González L, Junquera S, Corte M, González-Dieguez M, Linares A, Barbón E, Fresno-Forcelledo M and Rodrigo L 2009 Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma Dig. Liver Dis. 41 740
36. Zhang J, Yuan Z-F, Wang Y, Chen W-H, Luo G-F, Cheng S-X, Zhuo R-X and Zhang X-Z 2013 Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery J. Am. Chem. Soc. 135 5068
37. Liu J, Zhang B, Luo Z, Ding X, Li J, Dai L, Zhou J, Zhao X, Ye J and Cai K 2015 Enzyme responsive mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo Nanoscale 7 3614-26
38. Kulkarni P S et al 2014 MMP-9 Responsive PEG cleavable nanovesicles for efficient delivery of chemotherapeutics to pancreatic cancer Mol. Pharmacology 11 2390
39. Luo Z, Hu Y, Xin R, Zhang B, Li J, Ding X, Hou Y, Yang L and Cai K 2014 Surface functionalized mesoporous silica nanoparticles with natural proteins for reduced immunotoxicity J. Biomed. Mater. Res. A 102 3781
40. Luo Z, Hu Y, Cai K, Ding X, Zhang Q, Li M, Ma X, Zhang B, Zeng Y and Li P 2014 Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity Biomaterials 35 7951
41. Lu J, Liong M, Li Z, Zink J I and Tamanoi F 2010 Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals Small 6 1794
42. Cai K, Hu Y, Luo Z, Kong T, Lai M, Sui X, Wang Y, Yang L and Deng L 2008 Cell-specific gene transfection from a gene-functionalized poly (d, l-lactic acid) substrate fabricated by the layer-by-layer assembly technique Angew. Chem. Int. Ed. Engl. 47 7479
43. Radu D R, Lai C-Y, Jeftinija K, Rowe E W, Jeftinija S and Lin V S-Y 2004 A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent J. Am. Chem. Soc. 126 13216
44. Pan Y-J, Chen Y-Y, Wang D-R, Wei C, Guo J, Lu D-R, Chu C-C and Wang C-C 2012 Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release Biomaterials 33 6570
45. Li L, Li H, Qian Y, Li X, Singh G K, Zhong L, Liu W, Lv Y, Cai K and Yang L 2011 Electrospun poly (ε-caprolactone)/silk fibroin core-sheath nanofibers and their potential applications in tissue engineering and drug release Int. J. Biol. Macromol. 49 223
46. Luo Z, Ding X, Hu Y, Wu S, Xiang Y, Zeng Y, Zhang B, Yan H, Zhang H and Zhu L 2013 Engineering a hollow nanocontainer platform with multifunctional molecular machines for tumor-targeted therapy in vitro and in vivo ACS Nano 7 10271
47. Schrand A M, Schlager J J, Dai L and Hussain S M 2010 Preparation of cells for assessing ultrastructural localization of nanoparticles with transmission electron microscopy Nat. Protocols 5 744
48. Liu J, Jiang X, Ashley C and Brinker C J 2009 Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery J. Am. Chem. Soc. 131 7567
49. Dhar S, Kolishetti N, Lippard S J and Farokhzad O C 2011 Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo Proc. Natl Acad. Sci. USA 108 1850
50. Meng H, Mai W X, Zhang H, Xue M, Xia T, Lin S, Wang X, Zhao Y, Ji Z and Zink J I 2013 Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo ACS Nano 7 994
51. Kong J and Yu S 2007 Fourier transform infrared spectroscopic analysis of protein secondary structures Acta Biochim. Biophys. Sin. 39 549
52. Jia X, Dang S, Cheng Y, Zhang X, Li M, Li Y and Li S 2012 Effects of saikosaponin-D on syndecan-2, matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in rats with hepatocellular carcinoma J. Tradit. Chin. Med. 32 415
53. Yang K, Xu H, Cheng L, Sun C, Wang J and Liu Z 2012 In vitro and in vivo near-infrared photothermal therapy of cancer using polypyrrole organic nanoparticles Adv. Mater. 24 5586
54. Idris N M, Gnanasammandhan M K, Zhang J, Ho P C, Mahendran R and Zhang Y 2012 In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers Nat. Med. 18 1580
55. Slowing I, Trewyn B G and Lin V S-Y 2006 Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells J. Am. Chem. Soc. 128 14792
56. Bae J A, Song K-C, Jeon J-K, Ko Y S, Park Y-K and Yim J-H 2009 Effect of pore structure of amine-functionalized mesoporous silica-supported rhodium catalysts on 1-octene hydroformylation Microporous Mesoporous Mater. 123 289
57. Maruyama T, Katoh S, Nakajima M, Nabetani H, Abbott T P, Shono A and Satoh K 2001 FT-IR analysis of BSA fouled on ultrafiltration and microfiltration membranes J. Membr. Sci. 192 201
58. Wang X, Chen H, Zheng Y, Ma M, Chen Y, Zhang K, Zeng D and Shi J 2013 Au-nanoparticle coated mesoporous silica nanocapsule-based multifunctional platform for ultrasound mediated imaging, cytoclasis and tumor ablation Biomaterials 34 2057
59. 2 nanoparticles with different particle sizes on a sub-200 nm scale Small 7 3026
60. Dai L, Li J, Zhang B, Liu J, Luo Z and Cai K 2014 Redox-responsive nanocarrier based on heparin end-capped mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo Langmuir 30 7867
61. Kim E-M, Jeong H-J, Kim S-L, Sohn M-H, Nah J-W, Bom H-S, Park I-K and Cho C-S 2006 Asialoglycoprotein-receptor-targeted hepatocyte imaging using 99 m Tc galactosylated chitosan Nucl. Med. Biol. 33 529
62. Yang J, Maity B, Huang J, Gao Z, Stewart A, Weiss R M, Anderson M E and Fisher R A 2013 G-protein inactivator RGS6 mediates myocardial cell apoptosis and cardiomyopathy caused by doxorubicin Cancer Res. 73 1662
63. Kalaria D R, Sharma G, Beniwal V and Ravi Kumar M N 2009 Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats Pharm. Res. 26 492